卡巴喹化学灭活疟原虫诱导长效免疫保护
该研究在小鼠肝期和血期疟原虫感染模型中评估卡巴喹(CBQ)感染加治疗策略能否诱导保护性免疫。结果显示肝期单剂CBQ诱导针对同源和异源子孢子攻击的持久保护,血期CBQ联合吡咯萘啶产生阶段特异性免疫并防止重症疟疾。
要点
- 肝期单剂CBQ诱导持久保护性免疫,减少疾病严重程度
- 血期CBQ联合吡咯萘啶产生阶段特异性免疫,限制寄生虫血症
- CBQ为口服感染加治疗策略提供概念验证,可补充现有疟疾疫苗
核心结论
- CBQ可在活体内化学灭活疟原虫并促进实验性疟疾的长效保护性免疫。
- 基于CBQ的感染加治疗策略可兼顾有效清除寄生虫与诱导保护性免疫应答。
- 该策略为补充现有疟疾疫苗接种和控制方法提供概念验证。
研究设计与样本
- 研究在小鼠肝期和血期疟原虫感染模型中评估CBQ感染加治疗策略。
主要发现
- 肝期单剂口服CBQ诱导针对同源和异源子孢子攻击的持久保护性免疫,并减少疾病严重程度。
- 肝期CBQ保护与肝脏驻留记忆CD8+ T细胞相关。
- 血期CBQ联合吡咯萘啶诱导阶段特异性免疫,限制寄生虫血症并防止同源或异源攻击后的重症疟疾。
临床怎么用
- 提示口服CBQ感染加治疗策略可能作为疟疾疫苗和控制的补充手段。
局限性
- 研究仅基于小鼠模型,尚未在人体中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Malaria remains a major global health challenge, and current vaccine strategies provide limited protection. Cabamiquine (CBQ), a Plasmodium translation elongation factor 2 inhibitor, arrests parasite growth during both the liver and blood stages of infection and may promote protective immune responses during controlled parasite infection. METHODS: We evaluated whether CBQ-based infection-and-treatment strategies could induce protective immunity in mouse models of liver- and blood-stage Plasmodium infection. Mice received a single oral dose of CBQ during liver-stage infection or CBQ in combination with pyronaridine during blood-stage infection and were subsequently challenged with homologous or heterologous Plasmodium parasites. RESULTS: CBQ treatment during liver-stage infection induced durable protective immunity against homologous and heterologous sporozoite challenge, reduced disease severity, and was associated with liver-resident memory CD8+ T cells. CBQ administered with pyronaridine during blood-stage infection elicited stage-specific immunity that limited parasitemia and protected against severe malaria following homologous or heterologous challenge. Together, these findings demonstrate that CBQ-based infection-and-treatment can combine effective parasite clearance with induction of protective immune responses following both liver- and blood-stage infections. CONCLUSIONS: CBQ enables in-life chemical inactivation of Plasmodium parasites while promoting long-lasting protective immunity in experimental malaria. These findings provide proof of concept for a simple oral infection-and-treatment strategy that could complement existing malaria vaccination and control approaches.
引用
- Demarta-Gatsi C, Moita D, Fontinha D, et al. In-life Chemical Inactivation of Plasmodium Parasites by Cabamiquine Induces Long Lasting Immune Protection. J Infect Dis. 2026. PMID: 42579294. doi:10.1093/infdis/jiag402
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。